Skip to content
An Initiative of AVAC
Search
Back to Resource Library

Frequently Asked Questions about the Dual Prevention Pill

1 April 2022

This factsheet provides answers to the most frequently asked questions about the Dual Prevention Pill (DPP), including what it is, who might use it, and how it can be rolled out.

Topic(s): Service Delivery

Product(s): Dual Prevention Pill, Multi-purpose Technologies

Population(s): Adolescent Girls and Young Women, Cisgender Women

Source(s): AVAC

Type: Document

Download

Featured Resources

External Link

Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative findings on MPT attribute preferences from the CUPID study (MTN-045)

This article from the Journal of the International AIDS Society uses data from the Microbicide Trials Network 045 study in Uganda and Zimbabwe to examine (1) how couples make decisions on existing non-Multipurpose Technology (MPT) HIV and pregnancy prevention products; (2) how couples make decisions on future ideal-MPT products; and (3) how these decision-making processes…
Presentation

Dual Prevention Pill Research Insights & Development of Strategic Themes

This presentation, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.
External Link

Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study

This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.
Document

DPP Audience & Provider Insights for the DPP Research and Marketing Plan: Phase 1 Research Findings

This report, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.
Presentation

Private sector delivery opportunities for the DPP: Lessons from FP for the introduction of MPTs

With anticipated rollout of the DPP just two years away, planning for where to introduce the DPP in the private sector will be critical for ensuring access, but will hinge on where PrEP delivery is already permitted. This webinar shares new findings on private sector opportunities for the DPP in Kenya, South Africa and Zimbabwe.…
Document

Private Sector Delivery Opportunities for the Dual Prevention Pill

This scoping report provides an updated assessment of the private sector delivery options for the dual prevention pill (DPP) in the three countries that are targeted for the initial roll out of the DPP: Kenya, South Africa, and Zimbabwe. The report builds upon previous assessments and analysis that the DPP Consortium have carried out recently,…
Document

Blazing a trail for MPT counseling: Efforts to develop recommendations for the Dual Prevention Pill and reconcile inconsistent guidance for delivering PrEP and oral contraception

This poster from AIDS 2022 describes a process for future efforts to develop appropriate counseling guidance for Multipurpose Technologies, based on learnings from the Dual Prevention Pill and using missed pills as an illustrative example.
Presentation

How Market Preparation for the Dual Prevention Pill is Reimagining Prevention Programs for a Future with MPTs

This slide deck presentation from AIDS 2022 describes how prevention programs can prepare for multipurpose prevention technology (MPTs) such as the Dual Prevention Pill, which combines protection against pregnancy and HIV, and offers marketing insights. The session also presents recommendations for provider counseling on a combined product. Watch the full session from AIDS 2022 here.
Document

Dual Prevention Pill Desk Review Insights

This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…
Document

Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill

This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.